Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAge Labs (BIOA) Net Income towards Common Stockholders (2024 - 2025)

BioAge Labs (BIOA) has disclosed Net Income towards Common Stockholders for 2 consecutive years, with -$25.7 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders fell 19.17% to -$25.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$80.4 million through Dec 2025, down 13.34% year-over-year, with the annual reading at -$80.4 million for FY2025, 13.34% down from the prior year.
  • Net Income towards Common Stockholders hit -$25.7 million in Q4 2025 for BioAge Labs, down from -$20.1 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$12.7 million in Q1 2024 to a low of -$25.7 million in Q4 2025.